Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 7.83549 | 93 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 8.27327 | 94 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 8.02013 | 93 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 7.57658 | 91 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 8.40599 | 95 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 7.83047 | 94 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 7.96771 | 94 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 8.42065 | 95 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 7.79725 | 93 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 7.65246 | 92 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 7.7951 | 93 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 7.63972 | 92 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 7.67076 | 92 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 7.83332 | 93 |